the tech entrepreneur and millionaire who became famous for infusing his son’s plasma into his blood in an effort to prolong his life, is now microdosing the popular weight-loss drug Zepbound ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Zepbound (tirzepatide) is only available on prescription for people with obesity, or those with overweight. Learn how to get Zepbound online, in-person, and through the drug’s manufacturer ...

It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

Not long after reporting phase 2 data for one of its obesity candidates that appeared to put it on par with Eli Lilly’s Zepbound ... improve the lives of people living with obesity,” Coleman ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide ... In a key secondary endpoint, 31.6% of people taking tirzepatide achieved at least 25% ...

This class of drugs, known as glucagon-like peptide-1 receptor agonists, or GLP-1s, also includes Wegovy and Zepbound ... for more than 2 million people taking diabetes medications – including ...